Anxiolytic drug discovery: what are the novel approaches and how can we improve them?

By Stewart Adam Michael   Kalueff Allan V  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 1, 2014-01 ,pp. : 15-26

Informa Healthcare

Access to resources Recommend Favorite

How can attrition rates be reduced in cancer drug discovery?

By Moreno Lucas   Pearson Andrew DJ  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 4, 2013-04 ,pp. : 363-368

Informa Healthcare

Access to resources Recommend Favorite

How far can virtual screening take us in drug discovery?

By Kar Supratik   Roy Kunal  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 3, 2013-03 ,pp. : 245-261

Informa Healthcare

Access to resources Recommend Favorite

How can we identify parasite genes that underlie antimalarial drug resistance?

By Anderson Tim   Nkhoma Standwell   Ecker Andrea   Fidock David  

Pharmacogenomics, Vol. 12, Iss. 1, 2011-01 ,pp. : 59-85

Future Medicine

Access to resources Recommend Favorite

Are we moving in the right direction with osteoarthritis drug discovery?

By Bondeson Jan  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 12, 2011-12 ,pp. : 1355-1368

Informa Healthcare

Access to resources Recommend Favorite